Compare SER & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SER | PHUN |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.0M | 55.9M |
| IPO Year | 2018 | N/A |
| Metric | SER | PHUN |
|---|---|---|
| Price | $3.37 | $2.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $13.00 | $7.25 |
| AVG Volume (30 Days) | 15.3K | ★ 162.3K |
| Earning Date | 11-13-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $116,000.00 | ★ $2,357,000.00 |
| Revenue This Year | $134.46 | N/A |
| Revenue Next Year | N/A | $73.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.15 | $1.83 |
| 52 Week High | $7.92 | $6.29 |
| Indicator | SER | PHUN |
|---|---|---|
| Relative Strength Index (RSI) | 34.09 | 43.86 |
| Support Level | $3.15 | $2.01 |
| Resistance Level | $4.26 | $2.16 |
| Average True Range (ATR) | 0.27 | 0.10 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 17.12 | 75.00 |
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.